DHP Korea Co. Ltd (131030) - Total Assets
Based on the latest financial reports, DHP Korea Co. Ltd (131030) holds total assets worth ₩175.59 Billion KRW (≈ $119.00 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See DHP Korea Co. Ltd net assets for net asset value and shareholders' equity analysis.
DHP Korea Co. Ltd - Total Assets Trend (2014–2024)
This chart illustrates how DHP Korea Co. Ltd's total assets have evolved over time, based on quarterly financial data.
DHP Korea Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
DHP Korea Co. Ltd's total assets of ₩175.59 Billion consist of 46.8% current assets and 53.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩6.00 Billion | 12.6% |
| Accounts Receivable | ₩13.66 Billion | 8.2% |
| Inventory | ₩12.50 Billion | 7.5% |
| Property, Plant & Equipment | ₩56.86 Billion | 34.2% |
| Intangible Assets | ₩16.07 Billion | 9.7% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how DHP Korea Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 131030 market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DHP Korea Co. Ltd's current assets represent 46.8% of total assets in 2024, a decrease from 59.1% in 2014.
- Cash Position: Cash and equivalents constituted 12.6% of total assets in 2024, down from 40.2% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is property, plant & equipment at 34.2% of total assets.
DHP Korea Co. Ltd Competitors by Total Assets
Key competitors of DHP Korea Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Yabao Pharmaceutical Group Co Ltd
SHG:600351
|
China | CN¥3.34 Billion |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Sandoz Group AG
SW:SDZ
|
Switzerland | CHF21.61 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr67.43 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.22 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
DHP Korea Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.49 | 6.62 | 10.89 |
| Quick Ratio | 1.89 | 5.49 | 10.10 |
| Cash Ratio | 0.00 | 0.39 | 0.00 |
| Working Capital | ₩35.37 Billion | ₩71.75 Billion | ₩84.85 Billion |
DHP Korea Co. Ltd - Advanced Valuation Insights
This section examines the relationship between DHP Korea Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.89 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 11.4% |
| Total Assets | ₩166.50 Billion |
| Market Capitalization | $92.87 Million USD |
Valuation Analysis
Below Book Valuation: The market values DHP Korea Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: DHP Korea Co. Ltd's assets grew by 11.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for DHP Korea Co. Ltd (2014–2024)
The table below shows the annual total assets of DHP Korea Co. Ltd from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩166.50 Billion ≈ $112.84 Million |
+11.40% |
| 2023-12-31 | ₩149.46 Billion ≈ $101.29 Million |
+9.70% |
| 2022-12-31 | ₩136.24 Billion ≈ $92.33 Million |
-2.71% |
| 2021-12-31 | ₩140.04 Billion ≈ $94.90 Million |
+7.81% |
| 2020-12-31 | ₩129.90 Billion ≈ $88.03 Million |
+9.19% |
| 2019-12-31 | ₩118.97 Billion ≈ $80.62 Million |
+14.50% |
| 2018-12-31 | ₩103.91 Billion ≈ $70.42 Million |
+9.87% |
| 2017-12-31 | ₩94.57 Billion ≈ $64.09 Million |
+12.79% |
| 2016-12-31 | ₩83.85 Billion ≈ $56.82 Million |
+14.64% |
| 2015-12-31 | ₩73.14 Billion ≈ $49.57 Million |
+8.53% |
| 2014-12-31 | ₩67.39 Billion ≈ $45.67 Million |
-- |
About DHP Korea Co. Ltd
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company… Read more